Based on our evaluation of the five key dimensions—Technical Signals, Moving Average trends, Short Sell Data, Similar Chart Pattern Matching and Seasonality Analysis—we have identified the following insights. XFOR has several positive signals and is within a rising trend, so we believe it will perform strongly in the next couple of days or weeks. We therefore hold a positive evaluation of this stock. Our analysis conclusion for this stock is a Strong Buy candidate.
XFOR stock price ended at $1.83 on Thursday, after rising22%
The X4 Pharmaceuticals Inc stock price increased by 22% on the last trading day (24 Jul 2025), rising from 1.51 to 1.83. Throughout the last trading session, the stock experienced a fluctuation of 49.01% , ranging from a day low of $1.51 to a day high of 2.25. The price has declined in 5 of the last 10 days, resulting in a total change of 16.56% during this period. On the last day, trading volume decrease by 14.99M shares, with the rising prices. This could serve as an early warning, indicating that risk may slightly increase in the coming days. In total, 15.76M shares were traded, amounting to approximately 31.72M.
XFOR Technical Signals
XFOR(X4 Pharmaceuticals Inc Corp) has 4 buy signals and 4 sell signals now. The current trend is downtrend starting from 2025-06-09. The total price change during this trend is -31.88%. Recently, the price has increased but the volume has decreased, indicating a potential warning signal. The average turnover of XFOR over the last 5 trading days is 998.01K. Overall, the technical indicator signals lean more toward a Neutral outlook in the mid-term.
XFOR Moving Average Analysis
X4 Pharmaceuticals Inc's overall moving average trend leans more bearish as of Friday, July 25, 2025, with 4 negative signals and 0 positive signal. In the mid-term, the SMA_20 being below the SMA_60 signals a strong bearish trend. There will be some resistance from the lines at $4.62, and $5.33. A break-up above any of these levels will issue buy signals. There will be some support from the lines at $2.32, and $1.61. A break-down below any of these levels will issue sell signals.
XFOR Short Selling Analysis
The short sale ratio of X4 Pharmaceuticals Inc(XFOR) as of 23 Jul 2025 is %, rising from last trading day. With increasing price from 1.49 to 1.50.
Technical Signal
Technical Signals Summary
Neutral
Sell
4
Buy
4
Moving Average
Swing
Negative
Stock Price Below SMA_5
Short Term
Negative
SMA_5 Below SMA_20
Mid Term
Negative
SMA_20 Below SMA_60
Long Term
Positive
SMA_60 Above SMA_200
Short Selling
Close Price
Short Sale Ratio
Short Sale Volume
4 Bullish Signals
4 Bullish Signals
When Value satisfies Signal, Indicator signals Bullish
Indicators
Signal
Value
Meaning
Stochastic Oscillator %K (14, 3, 3)
STOCHk_14_3_3 < 20
6.836
Bullish
Stochastic RSI %K (14, 14, 3, 3)
STOCHRSIk_14_14_3_3 < 20
3.43
Bullish
Williams %R (14 days)
WILLR_14 < -80
-89.252
Bullish
Ultimate Oscillator (7, 14, 28)
UO_7_14_28 < 30
26.755
Bullish
4 Bearish Signals
4 Bearish Signals
When Value satisfies Signal, Indicator signals Bearish
In 2026, X4 Pharmaceuticals Inc (XFOR) is anticipated to change hands in a trading channel between $0.00 and $0.00.
X4 Pharmaceuticals Inc Stock Forecast 2026
XFOR Price Prediction & Forecast by Similar Chart Analysis
Based on historical patterns and backtesting of stocks with similar movements to X4 Pharmaceuticals Inc(XFOR), our algorithm predicts XFOR's 1-month price at $3.14, with an 11.31%upwardshift. Using a similarity score up to 92.59%and other factors, This forecast updates weekly, adjusting for significant deviations.
Similar Chart
The price prediction chart for X4 Pharmaceuticals Inc (XFOR.O) stock, as of Sunday, June 15, 2025 , forecasts a 11.31% change over the next month, based on its high correlation with SCVL.O stock patterns. The similarity between their price movements over the analyzed periods is 92.59%. The right panel lists other stocks with similar price patterns. This prediction is updated every week.
XFOR
Future prediction
Up: 11.31%
SCVL
Up: 11.31%Similarity: 92.59%
Name
Similarity
Up/Down
SCVL.O
92.59%
+11.31%
AMRX.N
91.73%
-23.95%
APH.N
91.55%
-7.72%
HCI.N
91.15%
+10.06%
FIS.N
91.04%
+0.70%
AMPH.O
90.96%
-6.77%
EFOI.O
90.80%
-0.44%
PLCE.O
90.67%
+12.19%
BTCM.N
90.62%
+4.52%
CAH.N
90.60%
-4.37%
XFOR Seasonality Analysis
Based on XFOR's historical stock price data across all years, the probability of a positive return in July is28.57%, suggesting it maynotbe an ideal month to invest in XFOR. In contrast,Februaryoffers the highest probability of positive returns at75.00%, making it a potentially strong month for investment.
However, this is only a prediction based on one method, and a comprehensive assessment of the stock's future trend should consider additional factors. Our final stock price commentary incorporates three main evaluation dimensions: technical signals, Moving Average trends, and similar chart pattern matching, with the first two dimensions carrying the primary weight to ensure a more robust and accurate forecast.
Monthly Seasonality
The radar chart shows that buying X4 Pharmaceuticals Inc (XFOR.O) stock in February has the highest probability of a positive return (75.00%), while October has the lowest probability (14.29%).
Performance Seasonality
The chart shows X4 Pharmaceuticals Inc. (XFOR)'s annual stock price return for the past three years, helping you analyze price trends and identify recurring trends on an annual basis.
Should I buy X4 Pharmaceuticals Inc (XFOR.O) stock?
Based on our evaluation of the five key dimensions—Technical Signals, Moving Average trends, Short Sell Data, Similar Chart Pattern Matching and Seasonality Analysis—we have identified the following insights. XFOR has several positive signals and is within a rising trend, so we believe it will perform strongly in the next couple of days or weeks. We therefore hold a positive evaluation of this stock. Our analysis conclusion for this stock is a Strong Buy candidate.
Which months have the highest win rate for buying X4 Pharmaceuticals Inc (XFOR.O) stock in a year?
The radar chart shows that buying X4 Pharmaceuticals Inc (XFOR.O) stock in February has the highest probability of a positive return (75.00%), while October has the lowest probability (14.29%).
How has X4 Pharmaceuticals Inc. (XFOR)'s stock price performed over the past three years?
XFOR's stock price fell by -12.35% in 2023,decreased by -16.84% in 2024, and went down by 91.89%in 2025.
Is XFOR a buy based on overall technical signals summary?
XFOR has 4 buy signals and 4 sell signals now. Overall the technical rating for XFOR is Neutral . Note that market conditions change all the time. In addition to technical ratings, keep an eye on the Valuation Level of XFOR.
What is the trend of X4 Pharmaceuticals Inc (XFOR)'s moving average?
X4 Pharmaceuticals Inc's overall moving average trend leans more bearish as of July 25 2025, with 4 negative signals and 0 positive signal.
What is price prediction for XFOR stock next month?
The price prediction chart for X4 Pharmaceuticals Inc (XFOR.O) stock, as of June 15 2025, forecasts a 11.31% change over the next month, based on its high correlation with SCVL stock patterns. The similarity between their price movements over the analyzed periods is 92.59%. The right panel lists other stocks with similar price patterns. This prediction is updated every week.
What is price prediction 2025 for XFOR Stock?
XFOR stock is predicted to reach **$4.20** by the end of 2025. The stock has recently undergone a 1-for-30 reverse split, which has initially led to a price drop but may stabilize as the market adjusts. The low RSI of 14.7 suggests oversold conditions, indicating a potential short-term bounce. However, the overall bearish trend and negative market sentiment may limit significant upside.
What is price prediction 2030 for XFOR Stock?
The price prediction for XFOR stock by 2030 is approximately **$4.30**. This estimate is based on the stock's current price of $3.53 and its potential to break above the Fibonacci resistance level of 4.30. The stock is expected to grow as it overcomes this resistance, supported by positive market conditions and company performance.